![]() Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers. | Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | ![]() Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases. | ||
Founding Date | Founding Date 2008 | Founding Date 1975 | Founding Date 1997 | Founding Date 2011 |
Type | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Friendswood, US HQ Phoenix, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations Lund, SE HQ | Locations Daix, FR HQ |
Employees | Employees 61013% increase | Employees 332 | Employees 118 | Employees 114 |
Valuation ($) | Valuation ($) 936.9 m | Valuation ($) N/A | Valuation ($) 285.9 m | Valuation ($) 231 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $344.2m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) €4.5m (FY, 2025) |
Cost of goods | Cost of goods $71m (FY, 2025) | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $273.2m (FY, 2025) | Gross profit $156.4m (FY, 2018) | Gross profit kr226.6m (FY, 2025) | Gross profit €7.9m (FY, 2025) |
Net income | Net income ($24.2m) (FY, 2025) | Net income $40.5m (FY, 2018) | Net income (kr332.9m) (FY, 2025) | Net income (€354.1m) (FY, 2025) |
Operating ⚠ | ||||
Patent Applications | Patent Applications 39 (FY, 2021) | Patent Applications 50 (Apr, 2020) | Patent Applications N/A | Patent Applications N/A |
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View company
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View company
Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
View company